The Middle EAST Neurological Disorder Drug Market was valued at USD 3.5 billion in 2024 and is projected to reach USD 7.2 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of neurological disorders, increased healthcare spending, and advancements in drug development technologies. The region is witnessing a...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek